Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)
NCT01376128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96
Last updated 2017-05-22
Summary
The objectives of this survey was to retrospectively collect and evaluate the information on the efficacy and safety of PAXIL tablets ("PAXIL", hereinafter) in pediatric subjects (aged under 18) with panic disorder under conditions of actual use.
Conditions
- Panic Disorder
Interventions
- DRUG
-
Paroxetine
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-03-31
- Primary Completion
- 2009-02-28
- Completion
- 2009-05-31
More Related Trials
-
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)
NCT00658372 ·Status: TERMINATED ·Phase: PHASE3
-
A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)
NCT00735267 ·Status: TERMINATED ·Phase: PHASE3
-
Fluoxetine for Anxious Children
NCT00000381 ·Status: COMPLETED ·Phase: PHASE3
-
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)
NCT00658008 ·Status: TERMINATED ·Phase: PHASE3
-
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)
NCT00658762 ·Status: TERMINATED ·Phase: PHASE3
-
Treatment for Anxiety in Children
NCT00000389 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
NCT00481325 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder
NCT00540098 ·Status: COMPLETED ·Phase: PHASE4
-
Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705)
NCT00725725 ·Status: TERMINATED ·Phase: PHASE2
-
Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS
NCT04015596 ·Status: TERMINATED ·Phase: PHASE4
-
A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder
NCT05260541 ·Status: TERMINATED ·Phase: PHASE2
-
Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents
NCT00352768 ·Status: TERMINATED ·Phase: PHASE4
-
Social Anxiety Disorder Study Of Paroxetine
NCT00318669 ·Status: COMPLETED ·Phase: PHASE3
-
6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)
NCT00738738 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ
NCT00088738 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Study Of Paroxetine in Women and Men
NCT00264654 ·Status: COMPLETED ·Phase: PHASE3
-
POC Study in Partially Responsive Generalized Anxiety Disorder
NCT02310568 ·Status: TERMINATED ·Phase: PHASE2
-
Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder
NCT00705380 ·Status: COMPLETED ·Phase: PHASE2
-
An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder
NCT00332891 ·Status: COMPLETED ·Phase: PHASE3
-
Special Investigation Of J Zoloft For Panic Disorder Patients
NCT00605917 ·Status: COMPLETED
-
Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder
NCT04592159 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults
NCT03828149 ·Status: COMPLETED ·Phase: PHASE1
-
Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder
NCT00836069 ·Status: TERMINATED ·Phase: PHASE3
-
Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)
NCT00560612 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder
NCT00195598 ·Status: COMPLETED ·Phase: PHASE3